News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIND Biosciences, Inc. to Present at the Cowen and Company 33rd Annual Health Care Conference



2/14/2013 6:57:33 AM

ND Biosciences, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called AccurinsTM, announced today that Scott Minick, BIND’s President and CEO, is scheduled to present at the Cowen and Company 33rd Annual Health Care Conference in Boston, on Monday, March 4, 2013, at 3:30 p.m. ET.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES